The assigned single protein target for DRUGMATRIX assay is Lipoxygenase 15-LO enzyme inhibition, which involves the substrate Linoleic acid. The properties of the assay include Reticulocytes as the assay cell type, Oryctolagus cuniculus as the assay organism, In vitro as the assay test type and Binding as the assay type description. Does this molecule demonstrate effectiveness in this assay?